TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34167318

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I concentrations at presentation and on serial testing
Number of subjects: 46092

Group type: EXPERIMENTAL
Intervention: 99th percentile and rule-in thresholds of 64 ng/L and 5-fold upper reference limit
Number of subjects: 46092

Group type: EXPERIMENTAL
Intervention: Troponin concentration and change in troponin
Number of subjects: 46092

Group type: EXPERIMENTAL
Intervention: Troponin concentrations at presentation
Number of subjects: 46092
Study: 32108686

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 150 µg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intrathecal saline (control)
Number of subjects: 61
Study: 34355538

Group type: EXPERIMENTAL
Intervention: Comprehensive vasodilation strategy
Number of subjects: 666

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 666
Study: 35085017

Group type: EXPERIMENTAL
Intervention: Equine-Assisted Activities and Therapies (EAAT) program conducted for 40 min twice a week for 16 weeks (32 lessons)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 46
Study: 32050214

Group type: EXPERIMENTAL
Intervention: IC-8 IOL (AcuFocus)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Symfony IOL (Johnson & Johnson Vision)
Number of subjects: 38
Study: 35513967

Group type: EXPERIMENTAL
Intervention: Upright standing position during urination
Number of subjects: 800

Group type: COMPARATOR
Intervention: Free position during urination
Number of subjects: 800
Study: 32108889

Group type: EXPERIMENTAL
Intervention: Integrated Care plus Be Well at Work (BWAW)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Integrated Care
Number of subjects: 253
Study: 36373545

Group type: EXPERIMENTAL
Intervention: Surgical fixation followed by mobilization in a walking boot for 6 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Nonsurgical management in a walking boot for 6 weeks
Number of subjects: 160
Study: 32381738

Group type: EXPERIMENTAL
Intervention: Decisional autonomy
Number of subjects: 3867

Group type: COMPARATOR
Intervention: Paternalistic advice
Number of subjects: 3867
Study: 36130191

Group type: EXPERIMENTAL
Intervention: 5-day artemether-lumefantrine (10-dose) regimen
Number of subjects: 177

Group type: COMPARATOR
Intervention: 3-day artemether-lumefantrine (6-dose) regimen
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 177
Study: 33619371

Group type: EXPERIMENTAL
Intervention: Sickle cell trait (HbAS)
Number of subjects: 7453

Group type: EXPERIMENTAL
Intervention: Genetically predicted malaria risk
Number of subjects: 7453

Group type: EXPERIMENTAL
Intervention: Intervention that halves the risk of malaria episodes
Number of subjects: 7453
Study: 32025814

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg/d) during immobilization and retraining
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo during immobilization and retraining
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 36082313

Group type: EXPERIMENTAL
Intervention: Intraductal removable stent (IRS) group
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235
Study: 33452188

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) with peer support
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 100
Study: 35094217

Group type: EXPERIMENTAL
Intervention: BCP intervention program (breastfeed care plus intervention program) with four home visits for breastfeeding support.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional care (control group).
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: BCP intervention program (breastfeed care plus intervention program).
Number of subjects: 32
Study: 33314877

Group type: EXPERIMENTAL
Intervention: Aquatic exercises plus deep-water running (AEDWR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Aquatic exercises only (AE)
Number of subjects: 48
Study: 35122575

Group type: EXPERIMENTAL
Intervention: Daily oral PrEP
Number of subjects: 132
Study: 35685488

Group type: EXPERIMENTAL
Intervention: New risk-prediction scoring system for sepsis in AP patients
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Common indicators (SIRS, BISAP, SOFA, qSOFA)
Number of subjects: 1295
Study: 32830368

Group type: EXPERIMENTAL
Intervention: Abstinence-optimized treatment (A-OT, n = 276)
Number of subjects: 574

Group type: COMPARATOR
Intervention: Recommended usual care (RUC, n = 298)
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: Post-TQD craving and anhedonia
Number of subjects: 574
Study: 36669909

Group type: EXPERIMENTAL
Intervention: Clinical decision support tool (electronic alert)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 420
Study: 33688908

Group type: COMPARATOR
Intervention: Enhanced usual care control
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Trauma Survivors Outcomes and Support collaborative care intervention
Number of subjects: 635
Study: 35233770

Group type: EXPERIMENTAL
Intervention: 36-hour workshop-based couple relationship education program
Number of subjects: 1320

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 1320
Study: 33230628

Group type: EXPERIMENTAL
Intervention: Oropharyngeal aspiration before position change
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oropharyngeal aspiration as needed (Control)
Number of subjects: 100
Study: 35093516

Group type: EXPERIMENTAL
Intervention: Carboplatin plus veliparib with paclitaxel
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Carboplatin with paclitaxel
Number of subjects: 634
Study: 32666172

Group type: EXPERIMENTAL
Intervention: Systemic prednisone administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orally administered isotretinoin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined intravitreal prophylactic approach of 5-fluorouracil and low molecular weight heparin
Number of subjects: 0
Study: 32818267

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for CAD detection based on facial photos
Number of subjects: 5796
Study: 33279182

Group type: EXPERIMENTAL
Intervention: Checkpoint inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel targets explored in early phase clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current evidence
Number of subjects: 0
Study: 35742460

Group type: EXPERIMENTAL
Intervention: Low-Risk class
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Paraphernalia Risk class
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: High Sex/Moderate Paraphernalia Risk class
Number of subjects: 464
Study: 32557346

Group type: EXPERIMENTAL
Intervention: Erlotinib with cow's milk (3.9% fat)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Erlotinib with water
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Erlotinib with esomeprazole (40 mg once daily 3 hours prior to erlotinib)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Erlotinib with milk
Number of subjects: 38
Study: 32341047

Group type: EXPERIMENTAL
Intervention: TextMe2 (text message‐based prevention programme)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 246
Study: 35244043

Group type: EXPERIMENTAL
Intervention: Qinghua Zhixie Decoction
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 464
Study: 32930659

Group type: EXPERIMENTAL
Intervention: Occupational advice intervention
Number of subjects: 154
Study: 36518481

Group type: EXPERIMENTAL
Intervention: BCO‐5 (thymoquinone-rich black cumin oil) at a dose of 200 mg/adult/day for 90 days
Number of subjects: 70
Study: 33516238

Group type: EXPERIMENTAL
Intervention: Bioavailable turmeric extract (BCM‐95®) 500 mg capsule two times daily
Number of subjects: 144

Group type: COMPARATOR
Intervention: Paracetamol 650 mg tablet three times daily
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Bioavailable turmeric extract (BCM‐95®)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 144
Study: 33768779

Group type: EXPERIMENTAL
Intervention: Training monitoring based on intensities around critical velocity (95, 100, 105 and 110% of CV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Different heart rate (HR) zones (EN1+, EN2, EN2+ and EN3)
Number of subjects: 20
Study: 32369199

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 220
Study: 32816874

Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg QW plus dapagliflozin 10 mg
Number of subjects: 695

Group type: COMPARATOR
Intervention: Exenatide QW plus placebo
Number of subjects: 695

Group type: COMPARATOR
Intervention: Dapagliflozin plus placebo
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Exenatide QW plus dapagliflozin
Number of subjects: 695
Study: 32877616

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training, thrice weekly for 6 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 77
Study: 32749890

Group type: EXPERIMENTAL
Intervention: AT + S
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: S
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AT
Number of subjects: 60

Group type: COMPARATOR
Intervention: C + placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AT + placebo
Number of subjects: 60
Study: 36121338

Group type: EXPERIMENTAL
Intervention: Manual diaphragm release plus inspiratory muscle training
Number of subjects: 52

Group type: COMPARATOR
Intervention: Inspiratory muscle training only
Number of subjects: 52
Study: 34343059

Group type: EXPERIMENTAL
Intervention: AI approaches for peptide-based drug discovery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AI-dependent prediction tools
Number of subjects: 0
Study: 33068133

Group type: EXPERIMENTAL
Intervention: Antepartum tactile imaging (ATI) probe examination
Number of subjects: 20
Study: 32006612

Group type: EXPERIMENTAL
Intervention: One or three breathlessness training sessions
Number of subjects: 158
Study: 35442486

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 600 mg once daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epoetin-alpha plus insulin therapy (Control)
Number of subjects: 60
Study: 34231802

Group type: EXPERIMENTAL
Intervention: Increased distraction (intervention)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Intensive care unit bed availability (scarcity)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Increased intensive care unit admission of vignettes inappropriate for intensive care unit admission in the distractor (intervention) arm
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Multiple choices
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no increased distraction)
Number of subjects: 125
Study: 35090520

Group type: EXPERIMENTAL
Intervention: Dulce Digital
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Dulce Digital‐Me‐Automated
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Dulce Digital‐Me‐Telephonic
Number of subjects: 414

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 414
Study: 34702869

Group type: EXPERIMENTAL
Intervention: CT-based motion analysis (CTMA)
Number of subjects: 10
Study: 33896814

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo material
Number of subjects: 104
Study: 33829706

Group type: EXPERIMENTAL
Intervention: Geometric deep learning model trained on right brain surface meshes with 6,000 faces
Number of subjects: 159

Group type: COMPARATOR
Intervention: Healthy older adults (control group)
Number of subjects: 159
Study: 33084082

Group type: EXPERIMENTAL
Intervention: Personalized trauma cue
Number of subjects: 611

Group type: COMPARATOR
Intervention: Neutral cue
Number of subjects: 611
Study: 32693185

Group type: EXPERIMENTAL
Intervention: Tradipitant 85 mg
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 33032622

Group type: EXPERIMENTAL
Intervention: UCLA Multidimensional Condom Attitudes Scale (MCAS)
Number of subjects: 500
Study: 34535615

Group type: EXPERIMENTAL
Intervention: Self-collected cervicovaginal brush samples for HPV testing
Number of subjects: 329
Study: 35010932

Group type: EXPERIMENTAL
Intervention: Moringa oleifera (MO) supplementation (2400 mg/day, 6 capsules daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 65
Study: 35320999

Group type: EXPERIMENTAL
Intervention: Clinical nursing pathway intervention
Number of subjects: 170

Group type: COMPARATOR
Intervention: Routine nursing in cardiology (Control)
Number of subjects: 170
Study: 32102807

Group type: EXPERIMENTAL
Intervention: narrative text messages plus financial incentive for 12 months (SMS+I)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: narrative text messages for 12 months (SMS only)
Number of subjects: 105

Group type: COMPARATOR
Intervention: waiting list control
Number of subjects: 105
Study: 35343114

Group type: EXPERIMENTAL
Intervention: 12-session relapse prevention (RP) program
Number of subjects: 48

Group type: COMPARATOR
Intervention: 12-session psychoeducation (PE) program
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both RP and PE groups
Number of subjects: 48
Study: 33648579

Group type: COMPARATOR
Intervention: Not applicable (no intervention reported)
Number of subjects: 173
Study: 35329004

Group type: EXPERIMENTAL
Intervention: Routine third trimester ultrasonography at 28–30 and 34–36 weeks’ gestation
Number of subjects: 12974

Group type: COMPARATOR
Intervention: Usual care (selective ultrasonography)
Number of subjects: 12974
Study: 32209650

Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 1072

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1072
Study: 34579077

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dietary Advice (DA)
Number of subjects: 50
Study: 33296347

Group type: EXPERIMENTAL
Intervention: Oral melatonin 3mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35894099

Group type: COMPARATOR
Intervention: Combination HIV prevention modalities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster vaccine effects on SARS-CoV-2 variants
Number of subjects: 0
Study: 34060609

Group type: EXPERIMENTAL
Intervention: Deep convolutional neural network (GSU-Net) for automated segmentation of the sellar region
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Deep convolutional neural network (GSU-Net) for predicting tumor consistency
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Automatic segmentation methods
Number of subjects: 163
Study: 33472438

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (60,000 IU/week) plus standard treatment for 3 months
Number of subjects: 42
Study: 33652263

Group type: EXPERIMENTAL
Intervention: Fragility Index (FI) of trials supporting drug approvals
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Patients who withdrew consent or were lost to follow-up
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: FI compared to patients who withdrew consent or were lost to follow-up
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Time trend of FI
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Overall survival as primary endpoint
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Palliative setting trials
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Trial sample size and duration of follow-up
Number of subjects: 81
Study: 32545057

Group type: EXPERIMENTAL
Intervention: Iron Folic Acid (IFA)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Multimicronutrient (MMN)
Number of subjects: 19
Study: 35060229

Group type: EXPERIMENTAL
Intervention: Topical triple combination (TXA 5% + OXZ 1.5% + BMT 0.33%) applied on the right side of the face
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical lipocream (placebo) applied on the left side of the face
Number of subjects: 40
Study: 34509684

Group type: EXPERIMENTAL
Intervention: 9% HFA + Silane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silane only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Airborne particle (50 µm)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MBP
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study: 32090655

Group type: EXPERIMENTAL
Intervention: Seeding with nodes high on in-degree centrality and/or inverse constraint
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random networks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Uniform threshold distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta 7,14 threshold distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher threshold standard deviations
Number of subjects: 0
Study: 35301726

Group type: EXPERIMENTAL
Intervention: CTI ablation using 400 gs FTI lesions (FTI400 group, n=26)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CTI ablation using 600 gs FTI lesions (FTI600 group, n=24)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Total population (not achieving first-pass CTI block)
Number of subjects: 50
Study: 32563116

Group type: EXPERIMENTAL
Intervention: Brief Negotiated Interview (BNI)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MOTIV)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No Brief Intervention (no BI)
Number of subjects: 61
Study: 35083951

Group type: EXPERIMENTAL
Intervention: Intravenous tirofiban
Number of subjects: 930

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 930
Study: 32536329

Group type: EXPERIMENTAL
Intervention: Screening for stroke using a structured questionnaire and neurological evaluation by stroke neurologists.
Number of subjects: 2156

Group type: EXPERIMENTAL
Intervention: Confirmed cases of stroke (41 cases).
Number of subjects: 2156

Group type: EXPERIMENTAL
Intervention: Assessment of vascular risk factors in stroke survivors.
Number of subjects: 2156
Study: 35522470

Group type: EXPERIMENTAL
Intervention: Web drama video series
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 34930459

Group type: EXPERIMENTAL
Intervention: Olyset® Plus (permethrin and piperonyl butoxide treated LLIN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olyset® Net (permethrin treated LLIN)
Number of subjects: 0
Study: 36394843

Group type: EXPERIMENTAL
Intervention: SAF312 (2.5%)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 24
Study: 32170033

Group type: EXPERIMENTAL
Intervention: Intravenous azithromycin 20 mg/kg every 24 hours for 3 days
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo (D5W) every 24 hours for 3 days
Number of subjects: 121
Study: 33156279

Group type: EXPERIMENTAL
Intervention: PLICS score system
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: PLICS score system with PLICS score ≥7
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: PLICS score >7 or 7 with unstable lateral mass fractures
Number of subjects: 354
Study: 32270176

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (twice weekly during induction, then weekly or every other week during optimization/maintenance)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (reduced from weekly to every other week)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (increased from every other week to weekly)
Number of subjects: 580
Study: 35588898

Group type: EXPERIMENTAL
Intervention: Ultrasound-facilitated catheter-directed thrombolysis plus anticoagulation
Number of subjects: 406

Group type: COMPARATOR
Intervention: Anticoagulation alone
Number of subjects: 406
Study: 32535591

Group type: EXPERIMENTAL
Intervention: Multicomponent lifestyle intervention over 8 months
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 97
Study: 35422167

Group type: EXPERIMENTAL
Intervention: Supine PCNL
Number of subjects: 7

Group type: COMPARATOR
Intervention: Standard prone PCNL
Number of subjects: 7
Study: 32441171

Group type: EXPERIMENTAL
Intervention: Rehydration for 10 minutes in 0.9% saline solution
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rehydration for 30 minutes in 0.9% saline solution
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rehydration for 60 minutes in 0.9% saline solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: Untreated control (no rehydration)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rehydrated CP vs. non-rehydrated CP in patients
Number of subjects: 40
Study: 32100373

Group type: EXPERIMENTAL
Intervention: Long day (LD; 16 L:8 D)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Short day (SD; 8 L:16 D)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (CTR; 12.5 L:11.5 D)
Number of subjects: 120
Study: 36410582

Group type: EXPERIMENTAL
Intervention: Filtek Bulk Fill Posterior Restorative
Number of subjects: 60

Group type: COMPARATOR
Intervention: Filtek Supreme XTE Universal Restorative
Number of subjects: 60
Study: 33568510

Group type: EXPERIMENTAL
Intervention: 3 doses of DNA GTU-MultiHIV B at week 0, 4, and 12, followed by 2 doses of LIPO-5 vaccine at week 20 and 24
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 32935748

Group type: EXPERIMENTAL
Intervention: DIY lambda-cyhalothrin LLIN
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Deltamethrin LLIN
Number of subjects: 21

Group type: COMPARATOR
Intervention: Untreated nets (control)
Number of subjects: 21
Study: 33737522

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 32
Study: 33011734

Group type: EXPERIMENTAL
Intervention: Lung-Protective Ventilation (LPV)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional Mechanical Ventilation (MV)
Number of subjects: 71
Study: 34912835

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 70